홈 › 만성 림프구성 백혈병 › 워싱턴 › Seattle
WA Seattle의 만성 림프구성 백혈병 임상 시험
만성 림프구성 백혈병 관련 연구 22개가 Seattle 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
피험자 모집 중3상
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center-First Hill, Seattle
- FHCC at Northwest Hospital, Seattle
- 외 1개
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
피험자 모집 중관찰 연구건강한 지원자 환영
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- 외 1개
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
피험자 모집 중3상
- Swedish Medical Center-First Hill, Seattle
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
피험자 모집 중2상
- Fred Hutchinson Cancer Center, Seattle
Sonrotoclax, Rituximab, and Zanubrutinib in Treating Participants With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Mantle Cell Lymphoma
피험자 모집 중2상
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
피험자 모집 중2상
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
Nemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
피험자 모집 중2상
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
피험자 모집 중1/2상
- Fred Hutchinson Cancer Research Center, Seattle
Acalabrutinib in Combination With Venetoclax for the Treatment of Refractory or Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, The AVENUE-2 Trial
피험자 모집 중2상
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
피험자 모집 중3상
- Swedish Medical Center Swedish Cancer Institute First Hill Campus, Seattle
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
피험자 모집 중1상
- Fred Hutch Cancer Center, Seattle
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
피험자 모집 중3상
- Fred Hutchinson Cancer Research Center, Seattle
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
피험자 모집 중3상
- Swedish Medical Center-Swedish Cancer Institute ( Site 0071), Seattle
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
피험자 모집 중1/2상
- Fred Hutchinson Cancer Research Center, Seattle
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
피험자 모집 중1/2상
- Research Site, Seattle
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
피험자 모집 중3상
- Fred Hutchinson Cancer Research Center, Seattle
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
피험자 모집 중3상
- Fred Hutchinson Cancer Research Center, Seattle
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
피험자 모집 중2상건강한 지원자 환영
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
피험자 모집 중4상
- Swedish Cancer Institute, Seattle
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
피험자 모집 중4상
- Swedish Cancer Institute, Seattle
Study of SGR-1505 in Mature B-Cell Neoplasms
피험자 모집 중1상
- Fred Hutchinson Cancer Center, Seattle
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
피험자 모집 중1상
- Swedish Cancer Institute, Seattle
다른 도시의 만성 림프구성 백혈병 시험
- Boston, MA연구 31개
- Columbus, OH연구 29개
- Durham, NC연구 28개
- Washington, DC연구 22개
- Rochester, MN연구 20개
- New York City, NY연구 20개
- Houston, TX연구 18개
- Baldwin Park, CA연구 18개
- Cincinnati, OH연구 15개
- Milwaukee, WI연구 15개
- Chicago, IL연구 14개
- Nashville, TN연구 13개
Seattle의 다른 연구
- 비소세포폐암연구 55개
- 암 (전체)연구 48개
- 전립선암연구 45개
- 급성 골수성 백혈병연구 40개
- 전이성 암연구 39개
- 유방암연구 37개
- 대장직장암연구 35개
- 폐암연구 34개
- 난소암연구 29개
- 췌장암연구 22개
- 다발성 골수종연구 22개
- 급성 림프모구성 백혈병연구 22개
ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.